Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer histotype, characterized by high biological aggressiveness and scarce treatment options. Recently, we have established a clinically relevant murine HCC model by co-expressing activated forms of v-akt murine thymoma vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Liu, Xianqiong, Hu, Junjie, Song, Xinhua, Utpatel, Kirsten, Zhang, Yi, Wang, Pan, Lu, Xinjun, Zhang, Jie, Xu, Meng, Su, Tao, Che, Li, Wang, Jingxiao, Evert, Matthias, Calvisi, Diego F., Chen, Xin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679026/
https://ncbi.nlm.nih.gov/pubmed/31277283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11070930
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados